In Brief: Vyrex acquisition plans terminated
This article was originally published in The Tan Sheet
Executive Summary
Vyrex acquisition plans terminated: La Jolla, Calif.-based developer of therapeutic products announces that it has terminated negotiations to acquire trace mineral and dietary supplement manufacturer and marketer Nutrition 21. "Our investigation of Nutrition 21 during the post-letter of intent phase of the acquisition revealed regulatory, intellectual property and operational issues that pose unacceptable risks to Vyrex," the company explains. The letter of intent agreement was announced Oct. 30 ("The Tan Sheet" Nov. 21, 1996, p. 21)...